Search research articles
Contact Us
Filters
Showing results (31-40 of 819) with videos related to
Page
of 82
Sort By:
Journal of Translational Medicine
|
October 1, 2023
The addition of anlotinib reduces the incidence of radiation and immunotherapy-induced pneumonia
Linlin Yang, Qian Zhao, Jinming Yu, et al.
Cancer Letters
|
December 3, 2014
Involved field irradiation for the treatment of esophageal cancer: is it better than elective nodal irradiation?
Liyang Jiang, Xin Zhao, Xue Meng, et al.
International Immunopharmacology
|
February 24, 2022
Treatment-related lymphopenia impairs the treatment response of anti-PD-1 therapy in esophageal squamous cell carcinoma
Tianwen Yin, Peiliang Wang, Jinming Yu, et al.
Cancer Medicine
|
February 9, 2019
Alerting the illusion of smoking improves quality of life in Chinese male cancer survivors
Juan Xia, Peng Wu, Jiwei Wang, et al.
Frontiers in Oncology
|
June 7, 2021
Prognostic Significance of SUVmax Combined With Lactate Dehydrogenase in Advanced Lung Cancer Patients Treated With Immune Checkpoint Inhibitor Plus Chemotherapy: A Retrospective Study
Linping Ke, Lu Wang, Jinming Yu, et al.
Medicine
|
June 21, 2018
Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery
Jinming Yu, Zhaoyan Ding, Yuanming Yang, et al.
Frontiers in Oncology
|
March 21, 2022
Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors
Li Li, Xiaoyuan Chen, Jinming Yu, et al.
Annals of Translational Medicine
|
September 27, 2019
Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients' clinical outcomes
Xin Wang, Jie Lu, Feifei Teng, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 18, 2011
Implementation of hypoxia measurement into lung cancer therapy
Xue Meng, Feng-Ming Spring Kong, Jinming Yu
Cancer Management and Research
|
August 21, 2018
Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitors
Yingming Zhu, Fen Zhao, Zhenxiang Li, et al.
Page
of 82
Search research articles
Search
Showing results (31-40 of 819) with videos related to
Sort By:
Page
of 82
Journal of Translational Medicine
|
October 1, 2023
The addition of anlotinib reduces the incidence of radiation and immunotherapy-induced pneumonia
Linlin Yang, Qian Zhao, Jinming Yu, et al.
Cancer Letters
|
December 3, 2014
Involved field irradiation for the treatment of esophageal cancer: is it better than elective nodal irradiation?
Liyang Jiang, Xin Zhao, Xue Meng, et al.
International Immunopharmacology
|
February 24, 2022
Treatment-related lymphopenia impairs the treatment response of anti-PD-1 therapy in esophageal squamous cell carcinoma
Tianwen Yin, Peiliang Wang, Jinming Yu, et al.
Cancer Medicine
|
February 9, 2019
Alerting the illusion of smoking improves quality of life in Chinese male cancer survivors
Juan Xia, Peng Wu, Jiwei Wang, et al.
Frontiers in Oncology
|
June 7, 2021
Prognostic Significance of SUVmax Combined With Lactate Dehydrogenase in Advanced Lung Cancer Patients Treated With Immune Checkpoint Inhibitor Plus Chemotherapy: A Retrospective Study
Linping Ke, Lu Wang, Jinming Yu, et al.
Medicine
|
June 21, 2018
Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery
Jinming Yu, Zhaoyan Ding, Yuanming Yang, et al.
Frontiers in Oncology
|
March 21, 2022
Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors
Li Li, Xiaoyuan Chen, Jinming Yu, et al.
Annals of Translational Medicine
|
September 27, 2019
Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients' clinical outcomes
Xin Wang, Jie Lu, Feifei Teng, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 18, 2011
Implementation of hypoxia measurement into lung cancer therapy
Xue Meng, Feng-Ming Spring Kong, Jinming Yu
Cancer Management and Research
|
August 21, 2018
Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitors
Yingming Zhu, Fen Zhao, Zhenxiang Li, et al.
Page
of 82